MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why PIII Stock surged +4.22% Today — RQD Quant Desk Flash
$4.20 +4.22% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $4.22
P3 Health Partners Inc. (Class A) (PIII) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $30.5M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $4.22 (+0.57%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (38/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.8% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-9% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for PIII)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (38/100 Composite)
🔍 WHY PIII SCORES 38/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+13/20 pts (34% of score)
FRED Regime × Technicals: 17% of 52W Range • RSI-14 at 32.2 (NEUTRAL RANGE)
▲ #2 Bullish Driver: Whale & Options Positioning+12/20 pts (32% of score)
20D Institutional Volume Accumulation (±12.5% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$4.95-16.4% Next Q
46
Q2 (-2Q)Grade D$4.14+0% Next Q
43
Q3 (-1Q)Grade D$4.14+1.4% Next Q
41
CurrentGrade D-$4.20-7.8% Hist 90D α
38
Trajectory: D (46) → D- (38)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a PIII Turnaround Squeeze
While PIII currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.74) and Max Pain ($4.41) forces dealer call-delta covering toward $17.73.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $PIII• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “PIII Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why PIII Stock surged +4.22% Today — RQD Quant Desk Flash
P3 Health Partners Inc. (Class A) (PIII) surged +4.22% to $4.20, trading at 17% of its 52-week range ($1.52 – $16.89). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 17% of its 52-week range ($1.52 – $16.89) with RSI-14 at 32.2 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $4.20 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 52% gross margin and $0 annual free cash flow.
Live PIII Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring PIII)
- ✓Walkthrough of PIII's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
PIII // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +51.62%🛡️ HOLDING TREND SUPPORT
2026-10-30O $4.20H $4.36L $3.84C $4.20VOL 19.7K
RES: $10.26SUP: $3.47SMA50: $6.74SMA200: $6.55
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
PIII Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -2.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on PIII today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for PIII. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for PIII today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (PIII)
Health Care Rank #726 of 1016
⚔️ DCGO vs PIII Full Matrix →
1. Head-to-Head Health Care Peer Comparison (PIII vs. DCGO, BMGL, EUDA, ALPS)
Industry: Medical/Nursing Services (29 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, P3 Health Partners Inc. (Class A) (PIII) ranks #726 by composite RQD confidence (38/100, grade D-) and #802 by equity capitalization ($30.5M). Within this direct 5-issuer industry benchmark cohort, PIII leads on earnings valuation at N/A trailing P/E, while PIII leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. BMGL currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with PIII at 38/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| PIII
ACTIVE
P3 Health Partners Inc. (Class A) | D- | 38/100 | — | — | -35.0% | +4.22% | $30.5M | Benchmark Subject |
| DCGO DocGo Inc. | D- | 43/100 | — | — | -35.0% | -2.43% | $27.0M | /dcgo-vs-piii → |
| BMGL Basel Medical Group Ltd | D+ | 58/100 | — | — | — | +3.26% | $36.0M | /bmgl-vs-piii → |
| EUDA EUDA Health Holdings Limited | D- | 39/100 | — | 43.9% | -35.0% | +1.31% | $46.4M | /euda-vs-piii → |
| ALPS ALPS Group Inc Ordinary Share | D+ | 57/100 | — | — | — | -0.03% | $54.1M | /alps-vs-piii → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001832511In its most recent audited fiscal period (FY2025, filed 2025-12-31), P3 Health Partners Inc. (Class A) (PIII) reported GAAP revenue of $1.46B (-2.8% vs. FY2024 revenue of $1.50B , and +15.2% cumulative change since FY2023) , GAAP net income of -$147.9M, operating cash flow of -$91.2M, and free cash flow of -$91.2M (+17.2% YoY). On the balance sheet, PIII closed FY2025 with $656.6M in total assets against $228.4M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 1/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.46B | -$147.9M | -$91.2M | -$91.2M | $656.6M | $228.4M |
| FY2024 (FY) | 2024-12-31 | $1.50B | -$135.8M | -$110.1M | -$110.1M | $783.4M | $108.9M |
| FY2023 (FY) | 2023-12-31 | $1.27B | -$57.8M | -$76.0M | -$76.0M | — | — |
3. PIII Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs PIII stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, P3 Health Partners Inc. (Class A) (NASDAQ: PIII) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $4.20 (+4.22% 1D, market cap $30.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, PIII ranks #726 in composite RQD confidence.
How does PIII compare to DCGO and BMGL in the Health Care sector?
Within the Health Care sector (Medical/Nursing Services), PIII carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, DCGO (DocGo Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $27.0M) and BMGL (Basel Medical Group Ltd) posts a D+ grade (58/100 RQD, P/E N/A, ROIC —, cap $36.0M). Among the 5-stock peer group, PIII leads on earnings multiple (N/A) while PIII leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for PIII?
Per PIII's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001832511), P3 Health Partners Inc. (Class A) generated $1.46B in revenue (-2.8% YoY), -$147.9M in net income, and -$91.2M in free cash flow against $656.6M in total assets and $228.4M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is PIII trading relative to its 50-day, 200-day, and 52-week technical levels?
PIII last traded at $4.20 (+4.22% on volume of 49,912 shares), positioning the stock -37.69% below its 50-day simple moving average ($6.74) and -35.88% below its 200-day simple moving average ($6.55). Across its 52-week range of $1.52 to $16.89, PIII sits at the 17.4% percentile with a 14-day RSI of 32.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($3.67 to $4.73).
PIII Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is PIII stock moving today?
Why PIII Stock surged +4.22% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.